TRL 1-4

Michael is a dynamic leader with a passion for bringing together diverse teams that can deliver novel ideas and innovations. His decade plus of experience in finance and strategy for maritime as well as aerospace, automotive, rail, and other transportation sectors has equipped him with a unique ability to tackle challenges requiring cross-industry collaboration and insight. Michael’s career has included both consulting and in-house positions at diversified corporations, often in fast-paced roles working directly alongside C-suite leadership. Seamlessly integrating distinct industries – in this case, one of the oldest forms of transportation in maritime combined with one of the newest in rocketry – requires an expansive and open-minded perspective. As Seagate Space’s Chief Executive Officer, Michael is responsible for bridging these worlds and setting the course of the company’s ambitious vision to become the maritime partner for the space industry. His career across multiple sectors and working extensively with leadership ranging from Fortune 500 companies to large public agencies has prepared him for this challenge. Michael is a CFA Charterholder and has completed graduate coursework in space operations at Embry-Riddle Aeronautical University. He holds degrees in economics from the University of Miami (B.A.) and Johns Hopkins University (M.S.).

Kevin Anjel Damoa is the inventor, engineer, and designer behind Glīd Technologies, where he's fundamentally reshaping how the world moves freight through autonomous road-to-rail vehicles and AI-powered coordination platforms. A 23-year logistics operator and dual-service U.S. military veteran, Kevin brings a rare blend of deep operational expertise and forward-looking innovation. His impactful career includes leadership roles at SpaceX, Northrop Grumman, Hydroplane, Harley Davidson, and XOS Trucks. Notably, at SpaceX, Kevin personally architected and scaled the flight module logistics division from the ground up, building the foundation for launch and recovery operations across multiple national sites. His unique fusion of hands-on design thinking and masterful systems execution now anchors Glīd’s mission to decarbonize freight, enhance labor efficiency, and revitalize underutilized infrastructure across ports, rail, and industrial corridors. Glīd’s innovative approach, powered by its AI logistics platform EZRA-1SIX, is projected to slash emissions by over 90% while comprehensively modernizing America’s supply chain. Kevin is deeply passionate about building solutions that serve both people and planet. He's leading the charge to reindustrialize America, creating dignified jobs and accessible pathways for workforce development, particularly within marginalized communities, and pioneering new standards in clean, resilient logistics. His work embodies engineering excellence fused with bold, human-centered evangelism, driving innovation that truly moves the world forward.

Navy Fighter Pilot, Air Force Reserve SOF; Naval Academy, Georgetown SFS, Harvard Business School; prior manufacturing specialist at McKinsey & Co.

Mechanical Engineer by Education. Mad Scientist Inventor by Practice. Entrepreneur by Heart. Building the next generation of ocean cargo transport.

Zachary Rapp is the Chief Executive Officer and Co-Founder at Sigma Genetics, bringing over 14 years of experience guiding disruptive, science-centric biotechnology products from discovery through preclinical development. At Sigma Genetics, Zach is leading the development of Magnetoporation™, a scalable, non-viral gene delivery platform, demonstrating its efficacy for CAR T cell engineering and intracellular genetic modifications. Under his leadership, Sigma Genetics has advanced multiple CAR T programs targeting hematologic malignancies and solid tumors in collaboration with Seattle Children’s Research Institute, Seattle Children's Therapeutics, and City of Hope, leveraging their GMP manufacturing capabilities, clinical expertise, and established regulatory pathways. Additionally, Zach is spearheading collaborations with the United States Air Force (USAF) and Bloodworks Northwest to develop lyophilized RBCs and blood products aimed at enhancing military and global blood supplies for combat trauma, solid tumor, and immunocompromised patients. Prior to Sigma Genetics, Zach served as the first hire and Director at Altoida Inc., pioneering a smartphone-based augmented reality technology utilizing readily available sensors to predict and monitor neurodegenerative diseases. In this role, he led business development efforts, secured strategic partnerships with global biopharmaceutical companies, advanced clinical adoption at leading medical centers, and successfully raised venture capital funding. Zach’s earlier experience includes his tenure as a consultant at Pharmagellan LLC, where he conducted detailed competitive and financial analyses of biotechnology products, portfolios, and companies. His scientific training at Columbia University and the Icahn School of Medicine at Mount Sinai focused on oncology and genetics, notably co-discovering and characterizing the secreted tumor suppressor PTEN-Long, a potent PI3K pathway inhibitor demonstrating robust tumor regression in preclinical models. This seminal research was published in Science, protected by multiple patents, selected by the National Cancer Institute’s Experimental Therapeutics program, and subsequently acquired for clinical development. He has authored several scientific and economic publications featured in leading journals such as Science, Cell, Surgery, and Forbes, demonstrating his proficiency in bridging scientific innovation with impactful industry insights.

We are building AGI for Cities. Cities are broken; we are fixing them by building unified camera networks and AI.